Terfalin cream 1% 15 g №1

Name:
Terfalin cream 1% in tubes 15g in a pack. No. 1 Main active ingredient Terbinafine Release form Cream Composition 1 g of cream contains: active substance: terbinafine hydrochloride 10 mg: excipients: sodium hydroxide, benzine alcohol, sorbitan monostearate, cetyl palmitate, cetyl alcohol, stearyl alcohol, polysorbate 60, isopropyl myristate, purified water.
Description:
White, low-odor, slippery, glossy cream Dosage: 15g Indications: Fungal infections of the skin caused by dermatophytes such as Trichophyton (e.g., T. rubrum, T. mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis, and Epiderrnophyton floccosum, such as athlete’s foot , smooth body skin and natural folds. Fungal infections of the skin caused by yeasts, mainly from the genus Candida (eg Candida albicans). Pityriasis versicolor, caused by Pityrosporum orbiculare (also known as Malassezia furfur). Contraindications Hypersensitivity to terbinafine, or to any other component that is part of the cream. Children’s age up to 12 years. Use during pregnancy and lactation Controlled studies in pregnant women have not been conducted. Animal studies have shown no risk to the fetus. When applied topically, less than 5% of the applied amount of terbinafine is absorbed. During pregnancy, the cream should not be used if there are no absolute indications. Terbinafine is excreted in breast milk in small amounts. It is not known whether this small amount in mother’s milk can have a negative effect on the baby. Therefore, Terfalin should not be used in nursing mothers. Babies should not come into contact with treated skin areas. Dosage and administrationAdults and children over 12 years of age: Terfalin can be applied to the skin once or twice a day. Before applying the cream, clean and dry the affected areas. The cream is applied in a thin layer on the affected skin and adjacent areas and rubbed lightly. For infections accompanied by diaper rash (under the mammary glands, in the interdigital spaces, between the buttocks, in the inguinal region), the places where the cream is applied can be covered with gauze, especially at night. Average duration of treatment: Dermatomycosis of the feet (interdigital), smooth skin of the body and natural folds: 1 week 1 time per day. Dermatomycosis of the feet plantar (“moccasin type”): 2 weeks 2 times a day. Skin candidiasis: 1 week 1 or 2 times a day. Pityriasis versicolor: 2 weeks 1 or 2 times a day. A decrease in the severity of clinical manifestations is usually noted in the first days of treatment. In case of irregular treatment or its premature termination, there is a risk of recurrence of the infection. If after two weeks of treatment there are no signs of improvement, the diagnosis should be verified. The use of the drug in the elderly There is no reason to assume that for the elderly it is required to change the dosage of the drug or that they have side effects that differ from those in younger patients. The use of the drug in children The safety and efficacy of the use of terbinafine cream in children under the age of 12 years have not been systematically studied. The use of the cream in children under the age of 12 is not recommended due to lack of clinical experience. Side effects At the site of application of the cream, local symptoms may occur, such as itching, peeling, pain or irritation, pigmentation disorders, burning, erythema or crusts. These local symptoms must be distinguished from general hypersensitivity reactions, including rash, which require immediate discontinuation of treatment. After accidental eye contact, eye irritation may occur. In rare cases, there may be a worsening of the course of the underlying fungal infection. Below, side effects are listed by class of systems and organs in accordance with the frequency of occurrence. Frequencies are classified as follows: very often (?1/10), often (?1/100, <1/10); infrequently (?1/1000, <1/100), rarely (?1/10000, <1/1000), very rarely (<1/10000). Within each frequency grouping, unwanted effects are presented in descending order of severity. Immune system disorders: Very rare: hypersensitivity reactions (urticaria, angioedema, anaphylactic shock). On the part of the organ of vision: Rare: irritation. Skin and subcutaneous tissue disorders: Common: skin peeling, itching. Uncommon: skin irritation, crusting, skin lesions, pigmentation, erythema, burning sensation. Rare: dry skin, contact dermatitis, eczema. Very rare: rash. General disorders and reactions at the injection site: Uncommon: pain or irritation at the application site. Rare: exacerbation of the underlying disease. If the listed side effects occur, as well as reactions not listed in the package insert, you should consult a doctor. OverdoseSymptoms Due to low systemic absorption, an overdose of terbinafine when applied topically is unlikely. Accidental ingestion of two tubes of cream containing 300 mg of terbinafine hydrochloride is comparable to taking one 250 mg tablet (corresponding to the standard adult oral dose). If large amounts of terbinafine cream are inadvertently swallowed, the expected side effects are similar to those observed after an overdose of terbinafine tablets. These include headache, nausea, epigastric pain, and dizziness. Treatment Removal of unabsorbed substance by administration of activated charcoal and, if necessary, symptomatic and supportive therapy. Interaction with other drugs Currently, drug interactions with topical application of the cream are unknown. Precautions The cream is for external use only. Avoid getting the drug in the eyes. In case of accidental contact of the cream with the eyes, they should be immediately rinsed thoroughly under running water. Terfalin Cream contains cetyl alcohol and stearyl alcohol, which can cause local skin reactions (eg contact dermatitis). Storage conditions Store at a temperature not exceeding 25 ° C, out of the reach of children. Buy Terfalin cream 1% 15 g №1 Price for Terfalin cream 1% 15 g №1